Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Investigating miRNA-lncRNA Interactions: Computational Tools and Resources.

Veneziano D, Marceca GP, Di Bella S, Nigita G, Distefano R, Croce CM.

Methods Mol Biol. 2019;1970:251-277. doi: 10.1007/978-1-4939-9207-2_14.

PMID:
30963497
2.

isoTar: Consensus Target Prediction with Enrichment Analysis for MicroRNAs Harboring Editing Sites and Other Variations.

Distefano R, Nigita G, Veneziano D, Romano G, Croce CM, Acunzo M.

Methods Mol Biol. 2019;1970:211-235. doi: 10.1007/978-1-4939-9207-2_12.

PMID:
30963495
3.

ncRNA Editing: Functional Characterization and Computational Resources.

Nigita G, Marceca GP, Tomasello L, Distefano R, Calore F, Veneziano D, Romano G, Nana-Sinkam SP, Acunzo M, Croce CM.

Methods Mol Biol. 2019;1912:133-174. doi: 10.1007/978-1-4939-8982-9_6. Review.

PMID:
30635893
4.

WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs.

Khawaled S, Suh SS, Abdeen SK, Monin J, Distefano R, Nigita G, Croce CM, Aqeilan RI.

Cancer Res. 2019 Apr 15;79(8):1784-1798. doi: 10.1158/0008-5472.CAN-18-0614. Epub 2019 Jan 8.

PMID:
30622118
5.

Editorial: Epitranscriptomics: The Novel RNA Frontier.

Nigita G, Acunzo M, Cho WCS, Croce CM.

Front Bioeng Biotechnol. 2018 Dec 4;6:191. doi: 10.3389/fbioe.2018.00191. eCollection 2018. No abstract available.

6.

Knockout of both miR-15/16 loci induces acute myeloid leukemia.

Lovat F, Fassan M, Sacchi D, Ranganathan P, Palamarchuk A, Bill M, Karunasiri M, Gasparini P, Nigita G, Distefano R, Veneziano D, Dorrance AM, Garzon R, Croce CM.

Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):13069-13074. doi: 10.1073/pnas.1814980115. Epub 2018 Nov 26.

7.

Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma.

Fattore L, Ruggiero CF, Pisanu ME, Liguoro D, Cerri A, Costantini S, Capone F, Acunzo M, Romano G, Nigita G, Mallardo D, Ragone C, Carriero MV, Budillon A, Botti G, Ascierto PA, Mancini R, Ciliberto G.

Cell Death Differ. 2019 Jul;26(7):1267-1282. doi: 10.1038/s41418-018-0205-5. Epub 2018 Sep 25.

8.

miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients.

Balatti V, Tomasello L, Rassenti LZ, Veneziano D, Nigita G, Wang HY, Thorson JA, Kipps TJ, Pekarsky Y, Croce CM.

Blood. 2018 Nov 15;132(20):2179-2182. doi: 10.1182/blood-2018-04-845115. Epub 2018 Sep 21.

PMID:
30242085
9.

The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia.

Calore F, Londhe P, Fadda P, Nigita G, Casadei L, Marceca GP, Fassan M, Lovat F, Gasparini P, Rizzotto L, Zanesi N, Jackson D, Mehta S, Nana-Sinkam P, Sampath D, Pollock RE, Guttridge DC, Croce CM.

Cancer Res. 2018 Dec 1;78(23):6680-6690. doi: 10.1158/0008-5472.CAN-17-3878. Epub 2018 Sep 12.

10.

RNA Methylation in ncRNA: Classes, Detection, and Molecular Associations.

Romano G, Veneziano D, Nigita G, Nana-Sinkam SP.

Front Genet. 2018 Jul 12;9:243. doi: 10.3389/fgene.2018.00243. eCollection 2018.

11.

Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer.

Nigita G, Distefano R, Veneziano D, Romano G, Rahman M, Wang K, Pass H, Croce CM, Acunzo M, Nana-Sinkam P.

Sci Rep. 2018 Jul 5;8(1):10222. doi: 10.1038/s41598-018-28528-1.

12.

Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin.

Drusco A, Fadda P, Nigita G, Fassan M, Bottoni A, Gardiman MP, Sacchi D, Calore F, Carosi M, Antenucci A, Casini B, Kelani H, Pescarmona E, Di Leva G, Zanesi N, Berger MS, Croce CM.

EBioMedicine. 2018 Apr;30:105-112. doi: 10.1016/j.ebiom.2018.03.022. Epub 2018 Mar 21.

13.

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.

Moshiri F, Salvi A, Gramantieri L, Sangiovanni A, Guerriero P, De Petro G, Bassi C, Lupini L, Sattari A, Cheung D, Veneziano D, Nigita G, Shankaraiah RC, Portolani N, Carcoforo P, Fornari F, Bolondi L, Frassoldati A, Sabbioni S, Colombo M, Croce CM, Negrini M.

Oncotarget. 2018 Feb 27;9(20):15350-15364. doi: 10.18632/oncotarget.24601. eCollection 2018 Mar 16.

14.

miRandola 2017: a curated knowledge base of non-invasive biomarkers.

Russo F, Di Bella S, Vannini F, Berti G, Scoyni F, Cook HV, Santos A, Nigita G, Bonnici V, Laganà A, Geraci F, Pulvirenti A, Giugno R, De Masi F, Belling K, Jensen LJ, Brunak S, Pellegrini M, Ferro A.

Nucleic Acids Res. 2018 Jan 4;46(D1):D354-D359. doi: 10.1093/nar/gkx854.

15.

tsRNA signatures in cancer.

Balatti V, Nigita G, Veneziano D, Drusco A, Stein GS, Messier TL, Farina NH, Lian JB, Tomasello L, Liu CG, Palamarchuk A, Hart JR, Bell C, Carosi M, Pescarmona E, Perracchio L, Diodoro M, Russo A, Antenucci A, Visca P, Ciardi A, Harris CC, Vogt PK, Pekarsky Y, Croce CM.

Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):8071-8076. doi: 10.1073/pnas.1706908114. Epub 2017 Jul 10.

16.

Selective targeting of point-mutated KRAS through artificial microRNAs.

Acunzo M, Romano G, Nigita G, Veneziano D, Fattore L, Laganà A, Zanesi N, Fadda P, Fassan M, Rizzotto L, Kladney R, Coppola V, Croce CM.

Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4203-E4212. doi: 10.1073/pnas.1620562114. Epub 2017 May 8.

17.

Noncoding RNA: Current Deep Sequencing Data Analysis Approaches and Challenges.

Veneziano D, Di Bella S, Nigita G, Laganà A, Ferro A, Croce CM.

Hum Mutat. 2016 Dec;37(12):1283-1298. doi: 10.1002/humu.23066. Epub 2016 Sep 5. Review.

PMID:
27516218
18.

MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment.

Leoncini PP, Bertaina A, Papaioannou D, Flotho C, Masetti R, Bresolin S, Menna G, Santoro N, Zecca M, Basso G, Nigita G, Veneziano D, Pagotto S, D'Ovidio K, Rota R, Dorrance A, Croce CM, Niemeyer C, Locatelli F, Garzon R.

Oncotarget. 2016 Aug 23;7(34):55395-55408. doi: 10.18632/oncotarget.10577.

19.

microRNA editing in seed region aligns with cellular changes in hypoxic conditions.

Nigita G, Acunzo M, Romano G, Veneziano D, Laganà A, Vitiello M, Wernicke D, Ferro A, Croce CM.

Nucleic Acids Res. 2016 Jul 27;44(13):6298-308. doi: 10.1093/nar/gkw532. Epub 2016 Jun 13.

20.

Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer.

Pekarsky Y, Balatti V, Palamarchuk A, Rizzotto L, Veneziano D, Nigita G, Rassenti LZ, Pass HI, Kipps TJ, Liu CG, Croce CM.

Proc Natl Acad Sci U S A. 2016 May 3;113(18):5071-6. doi: 10.1073/pnas.1604266113. Epub 2016 Apr 11.

21.

MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors.

Rossi M, Colecchia D, Ilardi G, Acunzo M, Nigita G, Sasdelli F, Celetti A, Strambi A, Staibano S, Croce CM, Chiariello M.

Oncotarget. 2016 Apr 12;7(15):20981-98. doi: 10.18632/oncotarget.8044.

22.

Computational Approaches for the Analysis of ncRNA through Deep Sequencing Techniques.

Veneziano D, Nigita G, Ferro A.

Front Bioeng Biotechnol. 2015 Jun 3;3:77. doi: 10.3389/fbioe.2015.00077. eCollection 2015. Review.

23.

A-to-I RNA Editing: Current Knowledge Sources and Computational Approaches with Special Emphasis on Non-Coding RNA Molecules.

Nigita G, Veneziano D, Ferro A.

Front Bioeng Biotechnol. 2015 Mar 25;3:37. doi: 10.3389/fbioe.2015.00037. eCollection 2015. Review.

24.

Knowledge in the Investigation of A-to-I RNA Editing Signals.

Nigita G, Alaimo S, Ferro A, Giugno R, Pulvirenti A.

Front Bioeng Biotechnol. 2015 Feb 24;3:18. doi: 10.3389/fbioe.2015.00018. eCollection 2015.

25.

VIRGO: visualization of A-to-I RNA editing sites in genomic sequences.

Distefano R, Nigita G, Macca V, Laganà A, Giugno R, Pulvirenti A, Ferro A.

BMC Bioinformatics. 2013;14 Suppl 7:S5. doi: 10.1186/1471-2105-14-S7-S5. Epub 2013 Apr 22.

26.

miRandola: extracellular circulating microRNAs database.

Russo F, Di Bella S, Nigita G, Macca V, Laganà A, Giugno R, Pulvirenti A, Ferro A.

PLoS One. 2012;7(10):e47786. doi: 10.1371/journal.pone.0047786. Epub 2012 Oct 19.

27.

miR-EdiTar: a database of predicted A-to-I edited miRNA target sites.

Laganà A, Paone A, Veneziano D, Cascione L, Gasparini P, Carasi S, Russo F, Nigita G, Macca V, Giugno R, Pulvirenti A, Shasha D, Ferro A, Croce CM.

Bioinformatics. 2012 Dec 1;28(23):3166-8. doi: 10.1093/bioinformatics/bts589. Epub 2012 Oct 7.

28.

Darbepoetin in the control of cancer-related anaemia.

Franchi F, Pastore C, Nigita G, Seminara P.

Clin Exp Med. 2008 Dec;8(4):225-7. doi: 10.1007/s10238-008-0003-3. Epub 2008 Sep 30.

PMID:
18825479
29.

Mitomycin C and etoposide in advanced colorectal carcinoma. A clinical and in vitro experience that focuses the problem of schedule dependence in combination therapy.

Seminara P, Pastore C, Iascone C, Cicconetti F, Nigita G, Ielapi T, Franchi F.

Chemotherapy. 2007;53(3):218-25. Epub 2007 Mar 15.

PMID:
17363844
30.

Failure of imaging techniques in revealing breast cancer progression.

Franchi F, Ielapi T, Gargano L, Pasciuti G, Nigita G, Seminara P.

Eur J Gynaecol Oncol. 2004;25(5):637-9.

PMID:
15493186
31.

[Benign cystic mesothelioma with multiple recurrences: a clinical case].

Bruni R, Nigita G, Pagani V, Bonaiuti G, Petrocca S, Terenzi A.

Chir Ital. 2003 Sep-Oct;55(5):757-60. Italian.

PMID:
14587121
32.

Adrenal metastatic placental site trophoblastic tumor. Case report.

Bruni R, Nigita G, Pagani Guazzugli Bonaiuti V, Petrocca S, Terenzi A.

Chir Ital. 2003 Mar-Apr;55(2):257-60.

PMID:
12744102
33.

[Surgical treatment of total rectal prolapse: Delorme's technique].

Mazzocconi G, Zechini F, Nigita G, Anselmi D, Terenzi A, Rossi Lemeni A, Mantella F, Sbaffi E.

G Chir. 2000 May;21(5):248-52. Italian.

PMID:
10862462
34.

[Gastric leiomyoblastomas: a clinical case report].

Mazzocconi G, Mantella F, Anselmi D, Nigita G, Terenzi A, Rossi Lemeni A, Sbaffi E.

G Chir. 2000 Apr;21(4):167-71. Review. Italian.

PMID:
10812772
35.

[Ileorectal anastomosis with a B.A.R. A clinical case report. Bowel anastomosis ring].

Massi G, Brocato R, Maurizi G, Truosolo B, Forti A, Nigita G.

Ann Ital Chir. 1993 May-Jun;64(3):315-8. Review. Italian.

PMID:
8109819

Supplemental Content

Loading ...
Support Center